Members Can Post Anonymously On This Site
Media event: Second spaceflight for Samantha Cristoforetti
-
Similar Topics
-
By NASA
1 min read
Preparations for Next Moonwalk Simulations Underway (and Underwater)
NASA Marshall will hold a candle-lighting ceremony and wreath placement at 9:30 a.m. CST. The ceremony will include remarks from Larry Leopard, associate director, and Bill Hill, director of Marshall’s Office of Safety and Mission Assurance. NASA/ Krisdon Manecke NASA’s Marshall Space Flight Center in Huntsville, Alabama, invites media to attend its observance of the agency’s Day of Remembrance at 9:30 a.m. CST Thursday, Jan. 23, in the lobby of Building 4221.
Day of Remembrance honors the members of the NASA family who lost their lives while furthering the cause of exploration and discovery.
The event will include brief remarks from NASA Marshall leaders, followed by a candle lighting and moment of silence for the crews of Apollo 1 and space shuttles Challenger and Columbia. Speakers will include:
Larry Leopard, associate director, technical. Bill Hill, director, Office of Safety and Mission Assurance. Media interested in attending the event must confirm by 12 p.m. Wednesday, Jan. 22, with Molly Porter at: molly.a.porter@nasa.gov.
The agency will also pay tribute to its fallen astronauts with special online content, updated on NASA’s Day of Remembrance, at:
https://www.nasa.gov/dor/
Molly Porter
Marshall Space Flight Center, Huntsville, Ala.
256-424-5158
molly.a.porter@nasa.gov
Share
Details
Last Updated Jan 21, 2025 EditorBeth RidgewayContactMolly Portermolly.a.porter@nasa.govLocationMarshall Space Flight Center Related Terms
Marshall Space Flight Center Explore More
5 min read Exoplanets Need to Be Prepared for Extreme Space Weather, Chandra Finds
Article 5 days ago 4 min read NASA Instrument on Firefly’s Blue Ghost Lander to Study Lunar Interior
Article 2 weeks ago 3 min read NASA to Test Solution for Radiation-Tolerant Computing in Space
Article 2 weeks ago Keep Exploring Discover Related Topics
Missions
Humans in Space
Climate Change
Solar System
View the full article
-
By NASA
NASA’s SPHEREx observatory will use a technique called spectroscopy across the entire sky, capturing the universe in more than 100 colors.Credit: BAE Systems Media accreditation is open for the launch of two NASA missions that will explore the mysteries of our universe and Sun.
The agency is targeting late February to launch its SPHEREx (Spectro-Photometer for the History of the Universe, Epoch of Reionization and Ices Explorer) observatory, a space telescope that will create a 3D map of the entire sky to help scientists investigate the origins of our universe. NASA’s PUNCH (Polarimeter to Unify the Corona and Heliosphere) mission, which will study origins of the Sun’s outflow of material, or the solar wind, also will ride to space with the telescope.
NASA and SpaceX will launch the missions aboard the company’s Falcon 9 rocket from Space Launch Complex 4E at Vandenberg Space Force Base in California.
Accredited media will have the opportunity to participate in a series of prelaunch briefings and interviews with key mission personnel, including a science briefing the week of launch. NASA will communicate additional details regarding the media event schedule as the launch date approaches.
Media interested in covering the launch must apply for media accreditation. The application deadline for U.S. citizens is 11:59 p.m. EST, Thursday, Feb. 6, while international media without U.S. citizenship must apply by 11:59 p.m., Monday, Jan. 20.
NASA’s media accreditation policy is available online. For questions about accreditation, please email: ksc-media-accreditat@mail.nasa.gov. For other mission questions, please contact the newsroom at NASA’s Kennedy Space Center in Florida at 321-867-2468.
Para obtener información sobre cobertura en español en el Centro Espacial Kennedy o si desea solicitar entrevistas en español, comuníquese con Antonia Jaramillo: 321-501-8425, o Messod Bendayan: 256-930-1371.
Updates about spacecraft launch preparations are available on the agency’s SPHEREx blog and PUNCH blog.
The SPHEREx mission will observe hundreds of millions of stars and galaxies in infrared light, a range of wavelengths not visible to the human eye. With this map, SPHEREx will enable scientists to study inflation, or the rapid expansion of the universe a fraction of a second after the big bang. The observatory also will measure the collective glow from galaxies near and far, including light from hidden galaxies that individually haven’t been observed, and look for reservoirs of water, carbon dioxide, and other key ingredients for life in our home galaxy.
Launching as a rideshare with SPHEREx, the agency’s PUNCH mission is made up of four suitcase-sized satellites that will spread out around Earth’s day-night line to observe the Sun and space with a combined field of view. Working together, the four satellites will map out the region where the Sun’s outer atmosphere, the corona, transitions to the solar wind, or the constant outflow of material from the Sun.
The SPHEREx observatory is managed by NASA’s Jet Propulsion Laboratory in Southern California for the Astrophysics Division within the agency’s Science Mission Directorate in Washington. The mission principal investigator is based jointly at NASA JPL and Caltech. Formerly Ball Aerospace, BAE Systems built the telescope, supplied the spacecraft bus, and performed observatory integration. The science analysis of the SPHEREx data will be conducted by a team of scientists located at 10 institutions in the U.S., two in South Korea, and one in Taiwan. Data will be processed and archived at IPAC at Caltech. The SPHEREx data set will be publicly available.
The agency’s PUNCH mission is led by Southwest Research Institute’s office in Boulder, Colorado. The mission is managed by the Explorers Program Office at NASA’s Goddard Space Flight Center in Greenbelt, Maryland, for NASA’s Science Mission Directorate. NASA’s Launch Services Program, based at NASA Kennedy, manages the launch service for the SPHEREx and PUNCH missions.
For more details about the SPHEREx mission and updates on launch preparations, visit:
https://science.nasa.gov/mission/spherex
-end-
Alise Fisher (SPHEREx)
Headquarters, Washington
202-617-4977
alise.m.fisher@nasa.gov
Sarah Frazier (PUNCH)
Goddard Space Flight Center, Maryland
202-853-7191
sarah.frazier@nasa.gov
Laura Aguiar
Kennedy Space Center, Florida
321-593-6245
laura.aguiar@nasa.gov
Share
Details
Last Updated Jan 13, 2025 EditorJessica TaveauLocationNASA Headquarters Related Terms
SPHEREx (Spectro-Photometer for the History of the Universe and Ices Explorer) Goddard Space Flight Center Heliophysics Jet Propulsion Laboratory Kennedy Space Center Polarimeter to Unify the Corona and Heliosphere (PUNCH) Science Mission Directorate View the full article
-
By NASA
Credit: NASA NASA Administrator Bill Nelson and Nicky Fox, associate administrator, Science Mission Directorate, will host a media teleconference at 1 p.m. EST, Tuesday, Jan. 7, to provide an update on the status of the agency’s Mars Sample Return Program.
The briefing will include NASA’s efforts to complete its goals of returning scientifically selected samples from Mars to Earth while lowering cost, risk, and mission complexity.
Audio of the media call will stream live on the agency’s website.
Media interested in participating by phone must RSVP no later than two hours prior to the start of the call to: dewayne.a.washington@nasa.gov. A copy of NASA’s media accreditation policy is online.
The agency’s Mars Sample Return Program has been a major long-term goal of international planetary exploration for more than two decades. NASA’s Perseverance rover is collecting compelling science samples that will help scientists understand the geological history of Mars, the evolution of its climate, and prepare for future human explorers. The return of the samples also will help NASA’s search for signs of ancient life.
For more information about NASA’s Mars exploration, visit:
https://nasa.gov/mars
-end-
Meira Bernstein / Dewayne Washington
Headquarters, Washington
202-358-1100
meira.b.bernstein@nasa.gov / dewayne.a.washington@nasa.gov
Share
Details
Last Updated Jan 03, 2025 EditorJessica TaveauLocationNASA Headquarters Related Terms
Mars Sample Return (MSR) Science Mission Directorate View the full article
-
By NASA
NASA/Kim Shiflett From left, CSA (Canadian Space Agency) astronaut Jenni Gibbons, NASA astronaut Andre Douglas, CSA astronaut Jeremy Hansen, and NASA astronauts Christina Koch, Victor Glover, and Reid Wiseman participate in a media day event on Monday, Dec. 16, 2024, inside the Vehicle Assembly Building at the agency’s Kennedy Space Center in Florida. Gibbons and Douglas are Artemis II backup crew members.
The Artemis II test flight will be NASA’s first mission with crew under the Artemis campaign, sending astronauts on a 10-day journey around the Moon and back.
Image Credit: NASA/Kim Shiflett
View the full article
-
By NASA
6 min read
Preparations for Next Moonwalk Simulations Underway (and Underwater)
In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.
Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).
From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists
Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.
A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.
From: Nuffield Department of Clinical Neurosciences
The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:
Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak). Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO? What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk? The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.
The following key findings are the main take-aways from the OCHMO independent assessment:
In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section). Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur. Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects. The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.
Summary Report About the Author
Sarah D. Childress
Share
Details
Last Updated Dec 31, 2024 Related Terms
Office of the Chief Health and Medical Officer (OCHMO) Human Health and Performance Humans in Space International Space Station (ISS) Explore More
2 min read Station Science Top News: Dec. 20, 2024
Article 2 weeks ago 4 min read Artemis II Core Stage Vertical Integration Begins at NASA Kennedy
Article 2 weeks ago 3 min read NASA, Axiom Space Change Assembly Order of Commercial Space Station
Article 2 weeks ago Keep Exploring Discover More Topics From NASA
Missions
Humans in Space
Climate Change
Solar System
View the full article
-
-
Check out these Videos
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.